TTBK2
Summary: This gene encodes a serine-threonine kinase that putatively phosphorylates tau and tubulin proteins. Mutations in this gene cause spinocerebellar ataxia type 11 (SCA11); a neurodegenerative disease characterized by progressive ataxia and atrophy of the cerebellum and brainstem. [provided by RefSeq, Aug 2009].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| tau tubulin kinase 2 | MIM:611695 | Ensembl:ENSG00000128881 | HGNC:HGNC:19141 | PA134913925 | 15q15.2 |
GO terms in TTBK2
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IDA | GO:0004672 | protein kinase activity |
| MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
| MF | IDA | GO:0004674 | protein serine/threonine kinase activity |
| MF | NAS | GO:0004674 | protein serine/threonine kinase activity |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005524 | ATP binding |
| MF | IPI | GO:0019894 | kinesin binding |
| MF | TAS | GO:0050321 | tau-protein kinase activity |
| MF | TAS | GO:0051010 | microtubule plus-end binding |
| CC | HDA | GO:0005615 | extracellular space |
| CC | IBA | GO:0005634 | nucleus |
| CC | IDA | GO:0005634 | nucleus |
| CC | IBA | GO:0005737 | cytoplasm |
| CC | IDA | GO:0005814 | centriole |
| CC | IDA | GO:0005829 | cytosol |
| CC | TAS | GO:0005829 | cytosol |
| CC | IDA | GO:0035869 | ciliary transition zone |
| CC | ISS | GO:0035869 | ciliary transition zone |
| CC | ISS | GO:0036064 | ciliary basal body |
| BP | IGI | GO:0000226 | microtubule cytoskeleton organization |
| BP | IDA | GO:0007026 | negative regulation of microtubule depolymerization |
| BP | ISS | GO:0007224 | smoothened signaling pathway |
| BP | IBA | GO:0018105 | peptidyl-serine phosphorylation |
| BP | IDA | GO:0018105 | peptidyl-serine phosphorylation |
| BP | ISS | GO:0021549 | cerebellum development |
| BP | ISS | GO:0021681 | cerebellar granular layer development |
| BP | ISS | GO:0021935 | cerebellar granule cell precursor tangential migration |
| BP | IGI | GO:0030334 | regulation of cell migration |
| BP | IMP | GO:0060271 | cilium assembly |
| BP | ISS | GO:0060271 | cilium assembly |
| BP | TAS | GO:0097711 | ciliary basal body-plasma membrane docking |
| BP | IMP | GO:1902817 | negative regulation of protein localization to microtubule |
| BP | IDA | GO:1904527 | negative regulation of microtubule binding |
Gene expression in normal tissue: TTBK2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in TTBK2
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-1852241 | Organelle biogenesis and maintenance |
| reactome | R-HSA-5617833 | Cilium Assembly |
| reactome | R-HSA-5620912 | Anchoring of the basal body to the plasma membrane |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD280 | CYTOCHALASIN B | 3 |
| iGMDRD123 | Isoevodiamine | 3 |
| iGMDRD901 | ELCPK | 3 |
| iGMDRD634 | SCHEMBL2608041 | 6 |
| iGMDRD85 | Ursolic acid | 3 |
| iGMDRD193 | Fqi1 | 3 |
| iGMDRD639 | YK 4-279 | 3 |
| iGMDRD427 | ABT737 | 2 |
| iGMDRD532 | Olaparib | 3 |
| iGMDRD150 | RITA | 2 |
| iGMDRD701 | NVP-AUY922 | 3 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD126 | Tipifarnib | 5 |
| iGMDRD772 | BRD4770 | 3 |
| iGMDRD512 | nutlin 3 | 3 |
| iGMDRD64 | Parbendazole | 3 |
| iGMDRD552 | AZD-1775 | 2 |
| iGMDRD246 | NPC26 | 3 |
| iGMDRD886 | Compound 1541A | 2 |
| iGMDRD300 | Tozasertib | 3 |
| iGMDRD74 | Idarubicin | 6 |
| iGMDRD286 | Nsc 632839 | 6 |
| iGMDRD188 | Piperlongumine | 3 |
| iGMDRD562 | Navitoclax | 3 |
| iGMDRD506 | Fedratinib | 4 |
| iGMDRD434 | BMS-536924 | 2 |
| iGMDRD782 | DC-45-A2 | 3 |
| iGMDRD441 | TW 37 | 3 |
| iGMDRD137 | Indisulam | 3 |
| iGMDRD158 | NSC141540 | 3 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in TTBK2

